Single-cell sequencing has never been easier to run and never easier to misinterpret. Today, you can pick a platform, send samples, and receive a dataset with thousands of cells and millions of reads. The technical barrier is low. The conceptual barrier is not. Most single-cell projects fail not because of sequencing quality, but because the experiment was never properly designed.
A pilot experiment is the fastest and most reliable way to determine whether your project design actually works.
Planning a single-cell experiment?
Download our services brochure to see how we support experimental design, pilot studies, and scalable single-cell analysis.
Why most single-cell projects fail before sequencing begins
Most projects begin with confidence. The tissue seems well characterized, the protocol is published, and the technology is considered “standard” in the field. Yet single-cell experiments are unusually sensitive to details that are easy to underestimate: sample handling, storage conditions, dissociation protocols, fixation chemistry, and tissue complexity. In single-cell experiments, small deviations can have a massive impact on data usability and on the biological conclusions we draw.
What a pilot experiment actually does
Researchers often view a pilot as a smaller version of the final experiment: a nice-to-have step that offers peace of mind while increasing cost and slowing progress. This perspective is misguided. As any scientist knows, few experiments work exactly as planned on paper. A pilot provides a controlled way to challenge assumptions before committing significant time, effort, and budget to the wrong design. It transforms assumptions into evidence.
Matching technology to biology: the first test of a pilot
First, a pilot tests whether the chosen technology actually fits the biology. Plate-based, droplet-based, and split-pool methods each impose different biases. What works for one tissue, question, or storage condition may quietly fail for another. Pilots often reveal that the “obvious” technology choice only becomes obvious in hindsight.
Scaling without guesswork: cells, depth, and real biological resolution
Second, a pilot forces an honest discussion about scale. Single-cell experimental design always balances the number of cells, sequencing depth, and biological resolution. More cells do not automatically yield better biology. Deeper sequencing does not necessarily clarify meaning; it may simply inflate costs. A pilot replaces intuition with data. It allows researchers to downsample cells and reads to empirically identify the sweet spot: how many cells are needed to detect a rare population? At what point does deeper sequencing just burn budget?
Separating real biology from technical artefacts
Third, a pilot exposes the boundary between biology and artefact. Stress responses, ambient RNA, doublets, and are not exceptions in single-cell data; they are the default. Without a well-designed pilot, researchers can easily mistake these artefacts for biological insight. With a pilot, they become visible and quantifiable.
What You Miss When You Skip the Pilot
If you test only one protocol and technology at a small scale and then scale up because the data looks “decent,” you may miss critical issues: a dissociation protocol that loses a key cell type, a technology that introduces excessive technical noise, or unexpected difficulties integrating the data with public reference datasets.
By the time these problems surface, they are often too expensive (or impossible) to fix.
What a good pilot will tell us
In short, a good pilot will us:
- Does your tissue of interest generate good data?
- Which of the many protocols and technologies available is the best fit?
- Did you aim for enough (or too many) cells?
- Are you over- or under-sequencing?
- Do you have the tools (or people) to analyze the data properly?
So when should you pilot? If you are introducing anything new (for example, a new tissue, sample storage method, technology, or biological question), a pilot will almost always save time & money while preventing potential major disasters.
The true cost of skipping a pilot
This is even more important because single-cell data rarely stand alone. Many projects now integrate bulk RNA-seq to contextualize signals or spatial transcriptomics to map cell states within tissue. If the single-cell foundation is unstable, bulk and spatial data amplify confusion rather than resolve it.
From a cost perspective, a pilot is trivial relative to the full experiment (typically accounting for 5–15% of the total budget). Yet it often determines whether the remaining 85–95% produces insight or noise. Skipping the pilot may seem efficient, but it usually has the opposite effect.
Single-cell success is iterative, not linear
The most robust single-cell studies follow a simple logic:
- formulate the biological question
- run a pilot
- refine the design
- scale intelligently
- validate with orthogonal methods
Single-cell sequencing is not a single experiment. It is an iterative strategy for navigating biological uncertainty. The pilot is where that strategy becomes scientific rather than hopeful.
Download our services brochure
